CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

Anfield Capital Management, LLC's Holding History (CIK: 0001602020)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022

Shares 391 Value ($000) $16 Avg Close $53.05 Range $38.94 - $66.31

Q3 2022

Shares 391 Value ($000) $26 Avg Close $72.47 Range $60.41 - $86.95

Q2 2022

Shares 373 Value ($000) $23 Avg Close $58.79 Range $42.51 - $75.42

Q1 2022

Shares 301 Value ($000) $19 Avg Close $62.79 Range $50.54 - $79.40

Q4 2021

Shares 136 Value ($000) $10 Avg Close $87.36 Range $67.15 - $112.39

Q3 2021

Shares 11 Value ($000) $1 Avg Close $125.59 Range $109.63 - $163.00

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2022	391	$16	$53.05	$38.94 - $66.31
Q3 2022	391	$26	$72.47	$60.41 - $86.95
Q2 2022	373	$23	$58.79	$42.51 - $75.42
Q1 2022	301	$19	$62.79	$50.54 - $79.40
Q4 2021	136	$10	$87.36	$67.15 - $112.39
Q3 2021	11	$1	$125.59	$109.63 - $163.00